News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,980 Results
Type
Article (44000)
Company Profile (363)
Press Release (667617)
Section
Business (210938)
Career Advice (2091)
Deals (36681)
Drug Delivery (99)
Drug Development (83866)
Employer Resources (172)
FDA (16570)
Job Trends (15412)
News (357330)
Policy (34039)
Tag
Academia (2656)
Alliances (51454)
Alzheimer's disease (1281)
Approvals (16500)
Artificial intelligence (156)
Bankruptcy (364)
Best Places to Work (11745)
Biotechnology (244)
Breast cancer (180)
Cancer (1357)
Cardiovascular disease (111)
Career advice (1749)
Cell therapy (278)
Clinical research (66775)
Collaboration (456)
Compensation (247)
COVID-19 (2711)
C-suite (109)
Data (1368)
Diabetes (167)
Diagnostics (6269)
Earnings (86714)
Employer resources (149)
Events (113547)
Executive appointments (369)
FDA (17206)
Funding (418)
Gene therapy (203)
GLP-1 (625)
Government (4511)
Healthcare (19009)
Infectious disease (2806)
Inflammatory bowel disease (118)
Interviews (324)
IPO (16655)
Job creations (4062)
Job search strategy (1498)
Layoffs (444)
Legal (8344)
Lung cancer (192)
Manufacturing (206)
Medical device (13297)
Medtech (13302)
Mergers & acquisitions (20140)
Metabolic disorders (450)
Neuroscience (1604)
NextGen Class of 2024 (6701)
Non-profit (4556)
Northern California (1648)
Obesity (260)
Opinion (207)
Patents (116)
People (58561)
Pharmaceutical (101)
Phase I (20768)
Phase II (29368)
Phase III (21969)
Pipeline (504)
Postmarket research (2682)
Preclinical (8913)
Radiopharmaceuticals (247)
Rare diseases (259)
Real estate (6246)
Regulatory (22613)
Research institute (2420)
Resumes & cover letters (360)
Southern California (1429)
Startups (3755)
United States (14961)
Vaccines (630)
Weight loss (190)
Date
Today (123)
Last 7 days (692)
Last 30 days (2920)
Last 365 days (36154)
2024 (35127)
2023 (40891)
2022 (52116)
2021 (56669)
2020 (55152)
2019 (47679)
2018 (35984)
2017 (33384)
2016 (32953)
2015 (38840)
2014 (32730)
2013 (27853)
2012 (29978)
2011 (30709)
2010 (28739)
Location
Africa (795)
Arizona (202)
Asia (40571)
Australia (6546)
California (3716)
Canada (1408)
China (294)
Colorado (172)
Connecticut (173)
Europe (86751)
Florida (513)
Georgia (130)
Illinois (379)
Indiana (224)
Maryland (627)
Massachusetts (2938)
Michigan (170)
Minnesota (285)
New Jersey (1078)
New York (1058)
North Carolina (752)
Northern California (1648)
Ohio (144)
Pennsylvania (907)
South America (1169)
Southern California (1429)
Texas (541)
Utah (106)
Washington State (401)
711,980 Results for "immune pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunic, Inc. to Participate in Investor Conference in December
November 26, 2024
·
5 min read
Press Releases
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
October 16, 2024
·
6 min read
Business
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
Immunic, Inc. announced financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 8, 2024
·
14 min read
Press Releases
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
July 24, 2024
·
7 min read
Defence’s AccuTOX Boosts and Synergizes with Immune Checkpoint Inhibitors
Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce that Defence’s Accum-002TM (“AccuTOX®") has different mode
July 1, 2024
·
5 min read
Press Releases
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
November 14, 2024
·
11 min read
Press Releases
Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
October 31, 2024
·
5 min read
Press Releases
Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity
December 5, 2024
·
6 min read
Drug Development
CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
CASI Pharmaceuticals, Inc. announced today the following: On April 12, 2024 CASI submitted the IND application to the FDA for CID-103 to support a phase 1/2 study of CID-103 in adults with chronic Immune Thrombocytopenia (ITP).
May 15, 2024
·
5 min read
Press Releases
Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders
December 9, 2024
·
3 min read
1 of 71,198
Next
